Form D · Biotechnology
EpiBiome, Inc.
South San Francisco, CA · CIK 0001655745
Offering snapshot reported Oct 15, 2015 · SEC filing
- Reported sold
- $5.59M Offering amount: $6.14M
- Investors reported
- 35 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 1, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 15, 2015 | Initial | $5,592,130 | No comparison | 35 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-249431
Source: Form D, filed Oct 15, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nicholas Conley | Director, Executive |
| Aaron Tynes Hammack | Director, Executive |
| Ping Chuan Tsai | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
329 Oyster Point Blvd., 3 Rd Floor
South San Francisco, CA, 94080
South San Francisco, CA, 94080